Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.13
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
8.13
0.00 (0.00%)
After-hours: Jun 27, 2025, 4:34 PM EDT
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,300 employees as of December 31, 2024. The number of employees increased by 450 or 5.73% compared to the previous year.
Employees
8,300
Change (1Y)
450
Growth (1Y)
5.73%
Revenue / Employee
$340,986
Profits / Employee
-$1,572
Market Cap
2.55B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMRX News
- 2 days ago - Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences - GlobeNewsWire
- 15 days ago - Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension - GlobeNewsWire
- 4 weeks ago - Amneal to Participate at Upcoming Investor Conferences in June - GlobeNewsWire
- 6 weeks ago - US FDA approves Amneal's migraine treatment - Reuters
- 6 weeks ago - Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults - GlobeNewsWire
- 7 weeks ago - Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S. - GlobeNewsWire
- 2 months ago - Amneal Pharmaceuticals, Inc. (AMRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Amneal Reports First Quarter 2025 Financial Results - Business Wire